{"name":"Linnaeus Therapeutics, Inc.","slug":"linnaeus-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPRGpIWm1CSzY2RmVBU2xpeEhEb1FZbDJOMERMcm9naXRuRHY5M2tBNjhhZnJ5YmNLTTk2MUJFU1hCcTBua2pvaEJqb055UFl4Y2ZlWjJfVkUzLURsN195Zm8xUFhWMjNBNzBLWk5OREl6dW5rSnNfRjBjR2Q5MzVIby11U2ZkaU4wMjNJbQ?oc=5","date":"2026-02-26","type":"pipeline","source":"Longevity.Technology","summary":"Linnaeus wins $22m to address aging before decline - Longevity.Technology","headline":"Linnaeus wins $22m to address aging before decline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxNMzNWWUpBMzlYeU5rSmVET1plYlhFaVByZEZtWlJQSENfU09XRWoyWlRPU2xTVEtUZ0liRU5aU0FMNHdTWFhraUhZXzdGcGF6N2ZpTzg3VVFaRU9RNjY1ZnhFMGNtQVlQM0RhY3pVVkM5RlBkcHFpTGRaeExraTFZNGxGWmJTV0szVEdEaU1IeE9kTWM5MF9WdVdzOHNtR3NFLWpGRld4YnVfUC1GRndrRXpKVm12V0ppc3NLVnlsYko1QmFRbW5qM09qZjdWYkdSb0g5WGlwZmVhTVY1emplR1pLMFJ4dlp1RFJBVFpjX3N5aS1FSUp6R0E0UE1IbkQ2Zzc3cVpjMkM?oc=5","date":"2026-02-24","type":"pipeline","source":"GlobeNewswire","summary":"Linnaeus Therapeutics Awarded Up to $22 Million from ARPA-H to Advance LNS8801 for Healthspan Preservation - GlobeNewswire","headline":"Linnaeus Therapeutics Awarded Up to $22 Million from ARPA-H to Advance LNS8801 for Healthspan Preservation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowJBVV95cUxOWnU3YnJCYzNuV0Y1RUFWQXpUYlFDTXhGa1hlMnhGRjAyRy01WXNJc05KSmd3RUVKZmV0aUxXWjVPbkV2dkhwb0s1NFdOWTRKSUVvYW8zdFNGSGJQSG5NMzFVQnB3WC12dS1ZQ3VPQnJ0a3pkVzdfTUlaMmV1bEp4VVJ1YS1QTmRBYlpJOGNYQ0c0M3VFcmZyeVhLTnJQcENYcmdkTHNWSmZiam45YlBwRVI0eHhJNkJPX0ZjdE1mZ2hOX0c5dVRNeUZtOU1LUzNpQjJhZ2NwNmpTQlBoSlh0VmpxbDBaWkZQX05YVmlvMFRzZXc2bnBRd2RrS3hNZFphTVhkT2hCc3BMUlliNHd3bXl3ZnJXa3M5NEFqR1ZNdHlERG_SAaMCQVVfeXFMTlp1N2JyQmMzbldGNUVBVkF6VGJRQ014RmtYZTJ4RkYwMkctNVlzSXNOSkpnd0VFSmZldGlMV1o1T25FdnZIcG9LNTRXTlk0SklFb2FvM3RTRkhiUEhuTTMxVUJwd1gtdnUtWUN1T0JydGt6ZFc3X01JWjJldWxKeFVSdWEtUE5kQWJaSThjWENHNDN1RXJmcnlYS05yUHBDWHJnZExzVkpmYmpuOWJQcEVSNHh4STZCT19GY3RNZmdoTl9HOXVUTXlGbTlNS1MzaUIyYWdjcDZqU0JQaEpYdFZqcWwwWlpGUF9OWFZpbzBUc2V3Nm5wUXdka0t4TWRaYU1YZE9oQnNwTFJZYjR3d215d2ZyV2tzOTRBakdWTXR5RERv?oc=5","date":"2026-02-04","type":"trial","source":"bolsamania.com","summary":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - bolsamania.com","headline":"Oncolytic Virus Clinical Trial Landscape Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwJBVV95cUxOQnVMZjBIMnRadVZZWkJTZGdNU3E0YkV6blU4ZTZwbEVuV09udVJvZDEzTFRmcjhjb1NhRDctNktxUHA1SmViU0xNYVNZejhOUS1XeFJVR3A2VzQ2MjAweE9EdHJJVzhMV0cxYUM0eF9CV0drVXhwbmQ2bHF2YzE5U2M5V0I5cUhtMXdFM1NjckE1dGhXR21uMzBfeWtaWEtkMkdkZnFZd1NDc3NldFFmVndCUEF3elRtNUJGMUpkLWF0UV9ITHpTOURBVS1KY3ZTN24tMWMzMlEyaGdVUXlLZ2JFRE5wWHhUODVFRGxfQlJTSXVkeTMtclBIbXVSQjJEdGxOSHFYdmxvRmtYUDN5RDdIY1NaRmZhQlpORm1oeXo1alRXbzh6SVUzT25SUlhWN3RXMkJJX1dFS2MyTF8wVjZzVGRqNkU?oc=5","date":"2025-10-23","type":"pipeline","source":"PR Newswire","summary":"Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Diagnostics and Immuno-Oncology Advances | DelveInsight - PR Newswire","headline":"Mismatch Repair Deficiency Market Forecasts Strong Expansion During the Forecast Period (2025-2034) Driven by Rising Dia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxNZGtWZHFNbTBHS1YyTU1ENWd4Y09VQ3ZPbWQ2NmZyUHlVbl8zdU5JR1hwbl9aN2xQdlNHaWNSdWV4cjlOdEhHMGVSeEtkaWlVOFN5dGRZZHRHLUN4b1dBUmFGNGVIcWhTTi1NTnNnb00yUDlkLXRzTWVtTFZyT1ozbUtGTmxlUnZzZmEwQkZXSEVIXzR1VkxDWlluLVRXR0tDdTZteTQ0V2ZFbGM3TmJjVWM1TEI4MUlHWnRCOEwydmx6YUtreVMybWJoUWxkSkZtb3dYb1VJNjVLSTdFNWotdGY1ZnlxdnNRWkt1Q2VCeGVvbVpfUWptOXlISkhNZ01FQWF3Zks5YWVJQ0FVYkVpV2x1TnVTdVpK?oc=5","date":"2025-06-09","type":"regulatory","source":"PR Newswire","summary":"HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020-2034) | DelveInsight - PR Newswire","headline":"HER2+ Gastric Cancer (including GEJ) Market to Increase at a Remarkable Growth Rate of 13% During the Study Period (2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxNdUpxT00wX2hRN1R5bDlPTjczZXRwWkpORWJsLWlTN1htNTQtQWU0MjJSVHJIeXdOZUQ2alZVZUgtek15aGhVa0RkejJjbGdzcFJIMi1sVDdFZ1o4aGNEdEhLWm4xbVFpTlBobWZvVzlXa0tDSDJsUHVnZnhlbXZKLXJsc0tFZkVYN0Q2R3VfcHZYNmVqdVg4YU1nY0xzQ0g4LTVSREg5cEF5eEZYc0JFZEpOb3ZVdXc4eGdmemx2UnlsbUJGX0JwZkVaVzJEX1NSZ2lzSTdwOUh5dkQxOXlwdmw2TngzMFBvaUhOUnJScFNSTDJKdGVsbTcwZmdrVFdDVmJFSzdGbW1uWmowaDgwNzV6SEktbGRWbUp1eHdXS3g?oc=5","date":"2025-03-26","type":"pipeline","source":"PR Newswire","summary":"Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million - PR Newswire","headline":"Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Fun","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxNVnhoLUdEYmpVSFRyckF2WWliM3hPRFFJOHBvMl9EdVl2cGVXVldCRGJzckVSbkdQMC1MOG80cmVHbmNLdVpvVlF4c0RfOFlfMV9kMkUya0RDczlwRTU4RW85RThvc19uMzJUT3JaUTVaMjkwU0xxR0JvYnhqQWJHNjZQaGFqR0Q0WlhuRkhmWG11eEJtRnlXc19hUng1SFNFak1fZF9HWGx4ZFdsR2xxR2FRTGc2dTd1RzczbElpNmloSl9FMUlEUjhZcURtWDRzSkN5dnZzenNPMjMxM3lXVUp3QlVDbXRKSmhKc3VNc19GeGc?oc=5","date":"2025-03-20","type":"pipeline","source":"PR Newswire","summary":"Linnaeus Therapeutics Announces Publication of Seminal Paper on LNS8801 in Cancer Research Communications - PR Newswire","headline":"Linnaeus Therapeutics Announces Publication of Seminal Paper on LNS8801 in Cancer Research Communications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOTWN1QkJjbW5FdS1RWmVkMElObUFQQU5ONEp6V0daQnhxNlNZYmczOVJqUmdENGZQczlUUWxCZkpJSTB1b0dUc3NkZUlTc3JiWlZBQXBJQ2RHS2ZFRHhyTkZEMDFPbFB3bFlKY3lRWW1aTDR2TEdtckEyS0hpeTUzdXJrUVhzVlpYdkJVOVBLanJrWk50dHpnZXBRUzVpYU5oVnowblB1MkplZGhWOGRxcjd1eGhaZnYzeE40ZVYyc2NIN3JrSDkwZWxHTUtZbGZocmV2bXRXMFlCQTRWNXMybTNwMlNlNlVWOXZkRFNXTUhvX3N2eUZnQ2hvZnR0SnlvTlFXZHAwdTVMNEVIWVE5YzBoNEtqQXc?oc=5","date":"2024-09-16","type":"trial","source":"PR Newswire","summary":"Linnaeus Therapeutics Announces Presentation of Positive Clinical Data of LNS8801 in Metastatic Melanoma at 2024 ESMO Annual Meeting - PR Newswire","headline":"Linnaeus Therapeutics Announces Presentation of Positive Clinical Data of LNS8801 in Metastatic Melanoma at 2024 ESMO An","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2024-06-25","type":"deal","source":"Business Wire","summary":"Monoclonal Antibody Collaboration and Licensing Deals Trends Report 2024 with Directory of 974 Partnering Deals Signed by the World's Leading Life Science Companies Since 2016 - ResearchAndMarkets.com","headline":"Monoclonal Antibody Collaboration and Licensing Deals Trends Report 2024 with Directory of 974 Partnering Deals Signed b","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOWEhnVS1MT0N0ajQ5cm5jeEFJdWdxdDdCVFhLRXplNVBxLW82NHhUMXlWcG16Vk9JcWwxVkgyMWdaNmR6V191TFpHUjJtYzl6RWxXN25fbHpXRnVRU0gtQTBFYUVfSkN1c3hpT2RaQ0MwalU0d281XzlrVWxKLU9heFdVTFI5LVRmcHhWMzNLVUJNclJHQWZpcC0xWUtENXFmbjhUSkYtR1lZR01nZ01pRnVldXdLN0Z2OWRxSGtwMDFEM2NsRFg2VEk2OGsyS3Y2UnJnTndMTVhmVk5URTRXVzhiRFVEWkhpV05tMncwUEpWMGxPTVZ2MjJKdjdDZHc?oc=5","date":"2024-04-02","type":"patent","source":"PR Newswire","summary":"Linnaeus Therapeutics Announces Issuance of Composition of Matter Patent for LNS8801 by the European Patent Office - PR Newswire","headline":"Linnaeus Therapeutics Announces Issuance of Composition of Matter Patent for LNS8801 by the European Patent Office","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AJBVV95cUxPQ1ZDNHlQZDRvdUY3OHNWSldZTmRMbUxEa0hkWl9SRzJIWGd1SUVEMTlUcU5LTElNQVAya0VTZEdWVGFLNm9wQVc3aU1Ob2R4NlpXdW96c2F2Z0lmM0t5ZTA4dERsSVlfbU5YYmQ2WXdVVVdUamwxVHotSThINWJxR3V4SDA0YXprbGk0bjR5WWoya282Ym1lWWhzNTVxYW56TkNnMzIxV1JrNW9SbkFsNDJEbDZDa1hDcUY5ckpORzBQcWVmMmV3aDhpOGJUSDI0bGpRS2RzR21wcURsTGE5QkxFcG5wMWNBRDgxbmRkbFpLSUtCQnRvSGJCYmY2RTBHcHpqTHBVcm1JdUpGQ1BiYm5CVndKNDdMS0stUEs0M3pMdFMycUdrU2VMeGtzbGhIdVlnVmxLUEQ3ODFBVDh1R1ctblQ3SUNlaUM1aUhxelNtbGNZbHN0OGF4aDI?oc=5","date":"2020-06-18","type":"regulatory","source":"PR Newswire","summary":"Linnaeus Therapeutics Granted U.S. FDA Fast Track Designation for LNS8801 for the Treatment of Patients with Metastatic or Unresectable Melanoma Who Have Progressed on Anti-PD-1/L1 Therapy - PR Newswi","headline":"Linnaeus Therapeutics Granted U.S. FDA Fast Track Designation for LNS8801 for the Treatment of Patients with Metastatic ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPYU5mTHBXa3YtRlc0cGNTUXV3Y1oyYTl6ZVFZN1hvTWZORVdGTG5zOFZNODdQVVVDTTFRYnpRWXd6M1hvVVFlMzYzUk5ZSXhDOGE5N0REUlpjblpGd3RpTUwtZWVtcnJVOGZEMlFOTVV4LTNRYzlhWTh4NHcwdDRZME80WjFPTnBKd2NQcU5KNkJ1R21WNF9UN3NoUl9rWnpqM0lYYnFmZjVWbkVPbUJxTlNzTm8?oc=5","date":"2019-09-17","type":"pipeline","source":"PR Newswire","summary":"Linnaeus Therapeutics Closes $12 Million Series B Financing - PR Newswire","headline":"Linnaeus Therapeutics Closes $12 Million Series B Financing","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}